 SAN DIEGO, May 17, 2021 PRNewswire -- Inhibrx, Inc. NASDAQ: INBX, a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today that the Company will be presenting at the following upcoming virtual investor conferences: Jefferies Healthcare Conference; Wednesday, June 2nd at 12:30 p.m. Pacific Time JMP Securities Life Sciences Conference; Thursday, June 17 th at 8:00 a.m. 